Skip to ContentSkip to Navigation
How to find us D. Giesen

Publications

(89)ZED88082A PET imaging to visualize CD8(+) T cells in patients with cancer treated with immune checkpoint inhibitor.

89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

Moleculaire beeldvorming met 89Zr-immunoPET in translationele studies op het gebied van immuuntherapie

Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

Probody therapeutic design of 89Zr-CX-072 promotes accumulation in PD-L1 expressing tumors compared to normal murine lymphoid tissue

Zr-89-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs

Zr-89-labeled anti-PD-L1 CX-072 PET imaging in human xenograft and syngeneic tumors

89Zr-labeled anti-PD-L1 CX-072 PET imaging in human xenograft and syngeneic tumors

Theranostics Using Antibodies and Antibody-Related Therapeutics

(89)Zr-Onartuzumab PET imaging of c-MET receptor dynamics

Read more